Filing Flows › CervoMed (CRVO) › Who owns the stock
Who owns CervoMed (CRVO) stock
36 funds reported CervoMed (CRVO) shares in their latest 13F filings, worth $8.3M in all. The largest holder is Vanguard Group ($2.8M). Last quarter 14 funds added to their stakes and 12 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 354,950 | $2.8M | increase | 2025-12-31 |
| Woodline Partners LP | 688,987 | $2.1M | new | 2026-06-30 |
| Vanguard Capital Management LLC | 316,202 | $980K | unchanged | 2026-06-30 |
| Sabby Management, LLC | 248,880 | $772K | new | 2026-06-30 |
| Geode Capital Management, LLC | 66,923 | $208K | decrease | 2026-06-30 |
| BlackRock | 53,845 | $167K | increase | 2026-06-30 |
| Avantax Advisory Services | 26,087 | $164K | increase | 2025-06-30 |
| Byrne Asset Management LLC | 50,050 | $147K | decrease | 2026-09-30 |
| Citizens Financial Group | 37,477 | $116K | unchanged | 2026-06-30 |
| Vanguard Fiduciary Trust | 36,151 | $112K | unchanged | 2026-06-30 |
| Jane Street Group, LLC | 32,231 | $100K | increase | 2026-06-30 |
| Thompson Davis | 29,750 | $92K | increase | 2026-06-30 |
| Virtu Financial LLC | 24,093 | $75K | new | 2026-06-30 |
| State Street | 20,527 | $64K | unchanged | 2026-06-30 |
| Cetera Investment Advisers | 19,622 | $61K | decrease | 2026-06-30 |
CervoMed's latest quarter
CervoMed, Q4 2025: revenue $9K (-100% year over year), net loss $8.1M, operating cash flow −$6.6M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CRVO stock?
By the latest 13F filings: Vanguard Group ($2.8M); Woodline Partners LP ($2.1M); Vanguard Capital Management LLC ($980K); Sabby Management, LLC ($772K); Geode Capital Management, LLC ($208K).
What is the short interest in CRVO?
1,208,132 shares were sold short at the 2026-10-15 settlement, -9.83% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.